Asia-Pacific IVF Devices and Consumables Market by Instruments (Sperm separation system, Cryosystem, Incubators, Ovum aspiration pump, Cabinet, Accessories and disposables), Reagents and Media (Cryopreservation, Semen processing, Ovum processing, Embryo culture) and Technology (Fresh Embryo, Frozen Egg, Donor Egg)- Opportunity Analysis and Industry Forecast, 2014 - 2020

March 2016 | 120 pages | ID: A693275B6DFEN
Allied Market Research

Abstracts

The Asia-Pacific IVF devices market is growing significantly mainly due to rising incidences of infertility, advancement in IVF techniques and growing healthcare per capita spending. Recent innovations in the IVF technology, such as embryoscope and capsule IVF, are expected to further drive the IVF devices market. However, strenuous maintenance issues and high cost associated with the devices hinders the growth of the market. The shift in adoption of conventional infertility treatments such as infertility-medication (clomid), by the advanced IVF technologies would open opportunities for the IVF devices market. However, the major challenge in Asia-Pacific IVF devices market is affordability of these devices by the small sized IVF clinics. Asia-Pacific IVF devices and consumables marketis expected to grow at a double digitCAGR from 2015 to 2020.
The Asia-Pacific IVF devices market is segmented into IVF instruments, reagents and media, technology, end users and geography. The instruments considered in this report include sperm separation system, cryosystem, incubator, imaging system, disposables and consumables ovum aspiration pump, IVF cabinet, micromanipulator, IVF-accessories and disposables and others. The capital equipment used during IVF procedures is the fastest growing devices owing to high usage. However, disposables and consumables used during IVF procedures are the highest revenue generating segment.
Based on reagents and media the market is categorized into, cryopreservation media, semen processing media, ovum processing media and embryo culture media. Cryopreservation media is the high revenue generating media owing to its large application during frozen IVF cycles. IVF devices and consumables market by techniques is categorized into, fresh embryo IVF, frozen egg IVF and donor egg IVF. Fresh embryo IVF cycles are the largest revenue generating segment, as couple seeking for IVF treatment would firstly opt for fresh IVF cycle.
The Asia-Pacific IVF devices market by end-users is segmented into clinics, hospitals, surgical centres and clinical research institutes. Clinics is the highest revenue generating end-user for IVF devices owing to its growing popularity across fertility destinations. The Asia-Pacific IVF devices market is analysed on the basis of geographical regions into China, India, Japan, and Australia among others. China and Japan are the leading revenue generating segmented, collectively accounted for about 54.8% of the market share in 2014. However, India would be the fastest growing region, owing to high demand for economic IVF services and availability of skilled labour workforce.
Product launch strategies are adopted mainly for the launch of micromanipulators systems, ovum aspiration pumps and IVF accessories among others. These technologies are used in both clinical and research fields. Companies profiled in this report include Vitrolife AB, Merck Serono, Inc., Irvine Scientific, Cooper Surgical, Inc., Cook Medical, Inc., Thermo Fisher Scientific, Inc., Genea Biomedx, Kitazato and OvaScience, Inc.
KEY MARKET BENEFITS

• An in-depth analysis of current research and clinical developments within Asia-Pacific IVF devices market is provided with key market dynamic factors that helps in understanding the behavior of market
• The projections in the report are made by analyzing the current market trends and future market potential in terms of value for the period of 20142020
• Country-wise healthcare IVF devices market conditions have been comprehensively analyzed in the report
• Competitive intelligence (of leading manufacturers and distributors of IVF devices) highlights the business practices followed by leading market players across the geographies
• SWOT analysis enables to study the internal environment of prominent companies for strategy formulation
• Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework

ASIA-PACIFIC IVF DEVICES MARKET KEY SEGMENTS:
The Asia-Pacific IVF devices market is segmented on the basis of instruments, reagents and media, techniques, end users and geography.
By Instruments

• Sperm separation system
• Cryosystem
• Incubators
• Imaging system
• Ovum aspiration pump
• Cabinet
• Micromanipulator
• Accessories and disposables
• Others

By Reagents and Media

• Cryopreservation media
• Semen processing media
• Ovum processing media
• Embryo culture media

By Technology

• Fresh Embryo IVF
• Frozen Egg IVF
• Donor Egg IVF

By End Users

• Clinics
• Hospitals
• Surgical centres
• Clinical research institutes

By Geography

• China
• India
• Japan
• Australia
• Other APAC

Contents

CHAPTER 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Audiences
1.1 Research Methodology
  1.1.1 Secondary Research
  1.1.2 Primary Research
  1.1.3 Analyst Tools and Models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 ASIA-PACIFIC IVF DEVICES MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Alternative Technologies
  3.2.1 Intrauterine Insemination (IUI) Technique
    3.2.1.1 Factors assessed for the procedure
    3.2.1.2 Reasons for use of the technique
    3.2.1.3 Benefits of this technique
    3.2.1.4 Risks
  3.2.2 Difference between IUI and IVF Technique
  3.2.3 GIFT Technique
    3.2.3.1 Difference between GIFT and IVF technique
  3.2.4 ZIFT Technique
    3.2.4.1 Differences between ZIFT and IVF technique
3.3 Replacing IVF Procedures by Fertility Drugs and Surgeries
  3.3.1 Female Infertility Treatments
    3.3.1.1 Limitations of fertility drugs
  3.3.2 Male Infertility Treatments
3.4 Costs Related to IVF Procedures
3.5 Role of Donors in the IVF Market
  3.5.1 Egg Donation
    3.5.1.1 Egg sharing
  3.5.2 Sperm Donation
  3.5.3 Embryo Donation
  3.5.4 Donation for Research
3.6 Surrogacy
  3.6.1 Legal Issues
3.7 Rise in Same Sex Couples
  3.7.1 Artificial Insemination
  3.7.2 Surrogate Mothers
  3.7.3 In-Vitro Fertilization
3.8 Advanced Technologies in IVF
  3.8.1 Capsule IVF
  3.8.2 Three Parent IVF
    3.8.2.1 Ethical concerns
  3.8.3 Mini IVF
    3.8.3.1 Advantages
    3.8.3.2 Drawbacks
  3.8.4 EmbryoScope
    3.8.4.1 Advantages
  3.8.5 PICSI
3.9 Fertility Treatment and Gender Selection
  3.9.1 Methods of Sex Selection
    3.9.1.1 Gradient method
    3.9.1.2 Flow cytometry technique
    3.9.1.3 Pre-implantation genetic diagnosis (PGD)
    3.9.1.4 Ethical and legal issues
3.10 Metabolomics in Embryo Screening Methods
3.11 Application of Stem Cells in IVF
3.12 IVF and Resource Poor Countries
3.13 Key Findings
  3.13.1 Top Factors Impacting for Asia-Pacific IVF Devices Market
  3.13.2 Top Winning Strategies for Asia-Pacific IVF Devices Market
3.14 Porters Five Forces Analysis
  3.14.1 Competition Declining Suppliers Power
  3.14.2 Availability of Options Impacting Buyer Power
  3.14.3 High Cost -A Hindrance to New Entrants
  3.14.4 Application of Strategies to Overcome Competition
  3.14.5 Less Threat from Substitutes
3.15 Value Chain Analysis
3.16 Patent Analysis
  3.16.1 Patent Analysis by Type of Patents
  3.16.2 Patents Analysis by Geography
3.17 Government Regulations
3.18 Clinical Trials
  3.18.1 Trial 1: To Study the DHEA Outcomes on Poor Responders of IVF
  3.18.2 Trial 2: Use of Metformin in IVF Treatment of Polycystic Ovary Syndrome
  3.18.3 Trial 3- Treatment of First Line Unexplained Infertility by IVF and IUI in Controlled Ovarian Stimulation
  3.18.4 Trial 4: Fast Track to IVF (FASTT) vs Conventional Infertility Treatment
  3.18.5 Trial 5: To Study the Evaluation of Multiple Doses of NT100 in Women with Repeated IVF Failures
3.19 Market Dynamics
  3.19.1 Drivers
    3.19.1.1 Delayed pregnancies in women
    3.19.1.2 Rise in global infertility rates
    3.19.1.3 Advancement in technology
    3.19.1.4 Rise in gamete donations
    3.19.1.5 Rise in disposable income
    3.19.1.6 Increase in success rates
  3.19.2 Restraints
    3.19.2.1 Cost constraints
    3.19.2.2 Ethical and legal issues
    3.19.2.3 Multiple pregnancies
    3.19.2.4 Low awareness level
  3.19.3 Opportunities
    3.19.3.1 Fertility tourism
    3.19.3.2 Growing number of fertility clinics
    3.19.3.3 Rise in same sex marriages

CHAPTER 4 BY INSTRUMENTS

4.1 Incubators
  4.1.1 Asia-Pacific IVF Incubators Market by Countries
4.2 Cryosystem
  4.2.1 Asia-Pacific IVF Cryosystem Market by Countries
4.3 Imaging System
  4.3.1 Asia-Pacific IVF Imaging System Market by Countries
4.4 Cabinet (Work Station)
  4.4.1 Asia-Pacific IVF Cabinets Market by Countries
4.5 Ovum Aspiration Pump
  4.5.1 Asia-Pacific IVF Ovum Aspiration Pump Market by Geography
4.6 Sperm Separation System
  4.6.1 Asia-Pacific IVF Sperm Separation System Market by Countries
4.7 Accessories and Disposables
  4.7.1 Semen Analysis Chamber
  4.7.2 Plastic Ware
  4.7.3 Oocyte Retrieval Needles
  4.7.4 Miscellaneous Disposables
  4.7.5 Asia-Pacific IVF Accessories and Disposable Market by Countries
4.8 Micro Manipulator System
  4.8.1 Asia-Pacific IVF Micromanipulator Market by Countries
4.9 Others
  4.9.1 Refrigerators
  4.9.2 Asia-Pacific IVF Other Instruments Market by Countries

CHAPTER 5 BY REAGENTS AND MEDIA

5.1 Cryopreservation Media
  5.1.1 Embryo Cryopreservation Media
  5.1.2 Sperm Cryopreservation Media
  5.1.3 Oocyte Cryopreservation Media
  5.1.4 Asia-Pacific IVF Cryopreservation Media Market by Countries
5.2 Semen Processing Media
  5.2.1 Asia-Pacific IVF Semen Processing Media Market by Countries
5.3 Ovum Processing Media
  5.3.1 Asia-Pacific IVF Ovum Processing Media Market by Countries
5.4 Embryo Culture Media
  5.4.1 Asia-Pacific IVF Embryo Culture Media Market by Geography

CHAPTER 6 BY TECHNIQUE

6.1 Fresh Embryo IVF
  6.1.1 Drivers
  6.1.2 Restraints
  6.1.3 Asia-Pacific Fresh Embryo IVF Market, by Countries
6.2 Frozen Egg IVF
  6.2.1 Reasons to Use this Technique
  6.2.2 Advantages of Frozen Egg IVF Technique
  6.2.3 Disadvantages of Frozen Egg IVF Technique
  6.2.4 Asia-Pacific Frozen Egg IVF Market by Countries
6.3 Donor Egg IVF
  6.3.1 Benefits of Donor Egg IVF Technique
  6.3.2 Risks Associated with Donor Egg IVF Technique
  6.3.3 Asia-Pacific Donor Egg IVF Market by Countries

CHAPTER 7 BY END USERS

7.1 Hospitals
  7.1.1 Asia-Pacific IVF Hospitals Market by Countries
7.2 Surgical Centers
  7.2.1 Asia-Pacific IVF Surgical Centres Market by Countries
7.3 Clinical Research Institutes
  7.3.1 Asia-Pacific IVF Clinical Research Institutes Market by Countries
7.4 Clinics
  7.4.1 Asia-Pacific IVF Clinics Market by Countries

CHAPTER 8 BY COUNTRIES

  8.1.1 Asia Pacific IVF Devices Market
  8.1.2 Asia-Pacific IVF Devices Market, by Country
    8.1.2.1 India IVF devices and consumables market
    8.1.2.2 China IVF devices and consumables market
    8.1.2.3 Japan IVF devices and consumables market
    8.1.2.4 Australia IVF devices and consumables market
    8.1.2.5 Others IVF devices and consumables market

CHAPTER 9 COMPANY PROFILE

9.1 Vitrolife AB
  9.1.1 Company Overview
  9.1.2 Company Snapshot
  9.1.3 Business Performance
  9.1.4 Strategic Moves and Developments
    9.1.4.1 Primary strategies
    9.1.4.2 Other strategies
  9.1.5 SWOT Analysis of Vitrolife AB
9.2 Merck Serono, Inc.
  9.2.1 Company Overview
  9.2.2 Company Snapshot
  9.2.3 Business Performance
  9.2.4 Strategic Moves and Developments
    9.2.4.1 Primary strategies
  9.2.5 SWOT Analysis of Merck Serono, Inc.
9.3 Irvine Scientific
  9.3.1 Company Overview
  9.3.2 Company Snapshot
  9.3.3 Business Performance
  9.3.4 Strategic Moves and Developments
    9.3.4.1 Primary strategy
  9.3.5 SWOT Analysis of Irvine Scientific
9.4 Cooper Surgical, Inc.
  9.4.1 Company Overview
  9.4.2 Company Snapshot
  9.4.3 Business Performance
  9.4.4 Strategic Moves and Developments
    9.4.4.1 Primary strategies
  9.4.5 SWOT Analysis of Cooper Surgical, Inc.
9.5 Cook Medical, Inc.
  9.5.1 Company Overview
  9.5.2 Company Snapshot
  9.5.3 Strategic Moves and Developments
    9.5.3.1 Primary strategies
  9.5.4 SWOT Analysis of Cook medical, Inc.
9.6 Thermo Fisher Scientific Inc.
  9.6.1 Company Overview:
  9.6.2 Company Snapshot
  9.6.3 Business Performance
  9.6.4 Strategic Moves and Developments
    9.6.4.1 Primary strategies
  9.6.5 SWOT Analysis of Thermo Fisher Scientific, Inc.
9.7 Genea Biomedx
  9.7.1 Company Overview
  9.7.2 Company Snapshot
  9.7.3 Strategic Moves and Developments
    9.7.3.1 Primary strategy
  9.7.4 SWOT Analysis of Genea Biomedx
9.8 KetaZato Corporation
  9.8.1 Company Overview
  9.8.2 Company Snapshot
  9.8.3 Strategic Moves and Developments
    9.8.3.1 Primary strategies
  9.8.4 SWOT Analysis of KetaZato Corporation
9.9 OvaScience, Inc.
  9.9.1 Company Overview
  9.9.2 Company Snapshot
  9.9.3 Business Performance
  9.9.4 Strategic Moves a nd Developments
    9.9.4.1 Primary strategy
  9.9.5 SWOT analysis of OvaScience, Inc.

List Of Tables

LIST OF TABLES

TABLE 1 COMPARISON BETWEEN IUI AND IVF PROCEDURES
TABLE 2 COMPARISON BETWEEN GIFT AND IVF TECHNOLOGY
TABLE 3 COMPARISON BETWEEN ZIFT AND IVF TECHNOLOGY
TABLE 4 AVERAGE SURROGACY COSTS, 2014
TABLE 5 COMPARISON BETWEEN TRADITIONAL AND GESTATIONAL SURROGACY
TABLE 6 COMPARISON BETWEEN MINI IVF AND CONVENTIONAL IVF TECHNOLOGY
TABLE 7 APPLICATIONS OF PGD TECHNOLOGY
TABLE 8 PRODUCT LAUNCH AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2012-2015
TABLE 9 AGREEMENT AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2012-2015
TABLE 10 COLLABORATION AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2012-2015
TABLE 11 GLOBAL DISPOSABLE INCOME, 2012
TABLE 12 IVF SUCCESS RATES BY AGE, EUROPE
TABLE 13 ASIA-PACIFIC IVF DEVICES MARKET BY INSTRUMENTS TYPES, 2014-2020 ($MILLION)
TABLE 14 TECHNOLOGICAL VARIABLES FOR COMMERCIAL IVF INCUBATORS
TABLE 15 ASIA-PACIFIC IVF INCUBATORS MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 16 ASIA-PACIFIC IVF CRYOSYSTEM MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 17 ASIA-PACIFIC IVF IMAGING SYSTEM MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 18 ASIA-PACIFIC IVF CABINETS MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 19 ASIA-PACIFIC IVF OVUM APIRATION PUMP MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 20 MOTILITY OF SPERMS RETRIEVED THROUGH SPERM SEPARATION SYSTEM
TABLE 21 ASIA-PACIFIC IVF SPERM SEPARATION SYSTEM MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 22 ASIA-PACIFIC IVF ACCESSORIES AND DISPOSABLE MARKET BY COUNTRIES, 2012-2020 ($MILLION)
TABLE 23 ASIA-PACIFIC IVF MICROMANIPULATOR MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 24 ASIA-PACIFIC IVF OTHER INSTRUMENTS MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 25 ASIA-PACIFIC IVF DEVICES MARKET BY REAGENTS AND MEDIA TYPES, 2014-2020 ($MILLION)
TABLE 26 ADVANTAGES AND DISADVANTAGES OF CRYOPRESERVATION PROCEDURES
TABLE 27 CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES
TABLE 28 ASIA-PACIFIC IVF CRYOPRESERVATION MEDIA MARKET, BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 29 COMMERCIALLY AVAILABLE SPERM PROCESSING MEDIA IN THE MARKET
TABLE 30 ASIA-PACIFIC IVF SEMEN PROCESSING MEDIA MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 31 ASIA-PACIFIC IVF OVUM PROCESSING MEDIA MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 32 EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES
TABLE 33 ASIA-PACIFIC IVF EMBRYO CULTURE MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 34 ASIA-PACIFIC IVF DEVICES MARKET BY TECHNIQUE, 2014-2020 ($MILLION)
TABLE 35 ASIA-PACIFIC FRESH EMBRYO IVF MARKET, BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 36 COMPARISON BETWEEN FRESH AND FROZEN EMBRYO TRANSFER PROCEDURES
TABLE 37 ASIA-PACIFIC FROZEN EGG IVF MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 38 ASIA-PACIFIC DONOR EGG IVF MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 39 ASIA-PACIFIC IVF DEVICES MARKET BY END USERS, 2014-2020 ($MILLION)
TABLE 40 ASIA-PACIFIC IVF HOSPITALS MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 41 ASIA-PACIFIC IVF SURGICAL CENTERS MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 42 ASIA-PACIFIC IVF CLINICAL RESEARCH INSTITUTES MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 43 ASIA-PACIFIC IVF CLINICS MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 44 ASIA-PACIFIC IVF DEVICES MARKET BY COUNTRIES, 2014-2020 ($MILLION)
TABLE 45 POLICIES BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT
TABLE 46 ASIA PACIFIC IVF DEVICES MARKET, 2014-2020 ($MILLION)
TABLE 47 ASIA-PACIFIC IVF DEVICES MARKET, BY COUNTRY, 2014-2020 ($MILLION)
TABLE 48 INDIA IVF DEVICES AND CONSUMABLES MARKET, 2014-2020 ($MILLION)
TABLE 49 CHINA IVF DEVICES AND CONSUMABLES MARKET, 2014-2020 ($MILLION)
TABLE 50 JAPAN IVF DEVICES AND CONSUMABLES MARKET, 2014-2020 ($MILLION)
TABLE 51 ASUTRALIA IVF DEVICES AND CONSUMABLES MARKET, 2014-2020 ($MILLION)
TABLE 52 OTHERS IVF DEVICES AND CONSUMABLES MARKET, 2014-2020 ($MILLION)
TABLE 53 VITROLIFE AB BUSINESS SNAPSHOT
TABLE 54 MERCK SERONO, INC BUSINESS SNAPSHOT
TABLE 55 IRVINE SCIENTIFIC BUSINESS SNAPSHOT
TABLE 56 COOPER SURGICAL, INC. BUSINESS SNAPSHOT
TABLE 57 COOK MEDICAL, INC. BUSINESS SNAPSHOT
TABLE 58 THERMO FISHER SCIENTIFIC INC. BUSINESS SNAPSHOT
TABLE 59 GENEA BIOMEDX BUSINESS SNAPSHOT
TABLE 60 KETAZATO CORPORATION BUSINESS SNAPSHOT
TABLE 61 OVASCIENCE, INC. BUSINESS SNAPSHOT

List Of Figures

LIST OF FIGURES

FIG. 1 IVF DEVICES MARKET DEFINITION
FIG. 2 IUI SUCCESS RATES BY AGE UK, 2014
FIG. 3 COST OF BASIC IVF TYPE PROCEDURES
FIG. 4 PERCENTAGE OF LIVE BIRTH USING DONOR EGGS IN U.S., 2013
FIG. 5 EMBRYOS CREATED USING DONOR EGGS, EUROPE,2012
FIG. 6 GLOBAL ADOPTION RATE BY TYPE OF SURROGACY
FIG. 7 TOP FACTORS IMPACTING GLOBAL IVF DEVICES MARKET 2014-2020
FIG. 8 TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES MARKET 20122015
FIG. 9 TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES MARKET, 2012-2015
FIG. 10 PORTERS FIVE FORCE ANALYSIS:
FIG. 11 VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
FIG. 12 PATENT ANALYSIS BY TYPE OF PATENTS (2011-2015)
FIG. 13 PATENT ANALYSIS BY GEOGRAPHY (2011-2015)
FIG. 14 EFFECT OF AGE ON FERTILITY
FIG. 15 COMPARISON OF THE MEDIAS USED IN EMBRYO CULTURE
FIG. 16 SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE, 2013, U.S.
FIG. 17 PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2013 (U.S.)
FIG. 18 LIVE BIRTH RATE PER CYCLE IN U.S. AFTER FROZEN EMBRYO TRANSFER, 2011
FIG. 19 VITROLIFE AB, SALES PER REGION, 2014
FIG. 20 VITROLIFE AB, REVENUES ($MILLION), 2012-2014
FIG. 21 SWOT ANALYSIS OF VITROLIFE AB
FIG. 22 MERCK SERONO SALES BY REGION, 2012
FIG. 23 SWOT ANALYSIS OF MERCK SERONO, INC.
FIG. 24 SWOT ANALYSIS OF IRVINE SCIENTIFIC
FIG. 25 SWOT ANALYSIS OF COOPER SURGICAL, INC.
FIG. 26 SWOT ANALYSIS OF COOK MEDICAL, INC.
FIG. 27 THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUES BY BUSINESS UNITS (2013)
FIG. 28 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2013)
FIG. 29 SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC.
FIG. 30 SWOT ANALYSIS OF GENEA BIOMEDX
FIG. 31 SWOT ANALYSIS OF KETAZATO CORPORATION
FIG. 32 SWOT ANALYSIS OF OVASCIENCE, INC.